2022年8月18日 星期四

The Coronavirus Brief: COVID-19's effects on the brain

And more pandemic news |

Email not displaying correctly? View it in your browser.
Thursday, August 18, 2022

Parsing COVID-19’s Long-Term Effects on the Brain

BY KYLA MANDEL

COVID-19 has proven capable of affecting nearly every part of the body—including the brain. A study of 1.28 million people who had the disease, published Aug. 17 in Lancet Psychiatry, sheds light on the often complex, and sometimes long-term, impacts of COVID-19 on the mind.

Analyzing data from patients in the U.S. and several other countries, researchers found that within the first two months of getting COVID-19, people were more likely to experience anxiety and depression than people who got a different type of respiratory infection. And for up to two years after, people remained at greater risk for conditions such as brain fog, psychosis, seizures, and dementia.

Long COVID—marked by at least one symptom that lingers after COVID-19—is a growing problem worldwide. Earlier research from the U.S. Centers for Disease Control and Prevention (CDC) estimates that roughly one in five people in the U.S. who gets COVID-19 develops it. This week’s study helps researchers further understand the manifestations of Long COVID.

The results “highlight the need for more research to understand why this happens after COVID-19, and what can be done to prevent these disorders from occurring, or treat them when they do,” said Maxime Taquet, the study’s lead author and a senior research fellow at the University of Oxford, in a statement.

Researchers found that the risks of poor neurological or psychiatric outcomes after infection with Delta were higher than the risks after infection with the original variant—and about the same as the risks after Omicron. The effects also varied by age group. Older adults ages 65 and up who had COVID-19 experienced brain fog, dementia, and psychotic disorders at a higher rate compared to adults of the same age who had other respiratory infections.

Among COVID-19 patients in this age group, 450 cases of dementia were found per 10,000 people, compared to 330 cases per 10,000 people who had other respiratory infections. Brain fog occurred at a higher rate, too: there were 1,540 cases per 10,000 people infected with COVID-19, compared to 1,230 cases per 10,000 people with other infections.

The results were less dramatic for younger groups. There was virtually no difference in dementia risk for people 64 years and younger who had either COVID-19 or another respiratory infection. For brain fog, there were 640 cases per 10,000 people who had COVID-19, compared to 550 cases per 10,000 people who had different respiratory infections.

Although children had a lower overall risk of poor brain outcomes compared to adults, they were still twice as likely to develop epilepsy or seizures within two years of being infected with COVID-19 (260 cases in 10,000) compared to children who had other respiratory infections. And while the risk of kids being diagnosed with a psychotic disorder remained low, the study authors did see an increase among children who had COVID-19 (18 in 10,000) compared to kids who had other respiratory infections (TK in 10,000).

Meanwhile, the risk of anxiety and depression wasn’t any greater for children who had COVID-19 than for those who had other respiratory infections. While mood and anxiety disorders were shown to peak during SARS-CoV-2 infections, these risks returned to a baseline after two months, after which the risk of anxiety and depression actually decreased among all ages studied.

“It is good news that the excess of depression and anxiety diagnoses after COVID-19 is short-lived, and that it is not observed in children,” said study author Paul Harrison, a professor in Oxford’s psychiatry department, in a statement. “However, it is worrying that some other disorders, such as dementia and seizures, continue to be more likely diagnosed after COVID-19, even two years later.”


TODAY'S CORONAVIRUS OUTLOOK

More than 593 million people around the world had been diagnosed with COVID-19 as of 8 a.m. E.T. today, and more than 6.4 million people have died. On Aug. 17, there were nearly 980,000 new cases and 4,094 new deaths confirmed globally.

Here's how the world as a whole is currently trending, in terms of cases:

And in terms of deaths:

Here's where daily cases have risen or fallen over the last 14 days, shown in confirmed cases per 100,000 residents:

And here's every country that has reported over 10 million cases:

The U.S. had recorded more than 93.2 million coronavirus cases as of 8 a.m. E.T. today. More than 1.03 million people have died. On Aug. 17, there were 138,089 new cases reported in the U.S., and 1,093 deaths were confirmed.

Here's how the country as a whole is currently trending in terms of cases:

And in terms of deaths:

Here's where daily cases have risen or fallen over the last 14 days, shown in confirmed cases per 100,000 residents:

All numbers unless otherwise specified are from the Johns Hopkins University Center for Systems Science and Engineering, and are accurate as of Aug. 18. To see larger, interactive versions of these maps and charts, click here.


Have suggestions for our COVID-19 newsletter? We'd love to hear from you. Fill out our survey here.


WHAT ELSE YOU SHOULD KNOW

COVID-19 booster shots updated to target the Omicron subvariants BA.4 and BA.5 will be available to people 12 years and older “in a few short weeks,” the White House’s COVID-19 response coordinator Dr. Ashish Jha told NBC News on Wednesday. Though BA.5 now accounts for nearly 90% of new cases in the country, it's impossible to predict what the COVID-19 landscape will look like once the shots are widely available.

Half of people with Omicron don’t know they’re infected, finds a study published this week. As my colleague Alice Park writes, this “underscores the fact that Omicron tends to cause relatively mild symptoms (or no symptoms at all) in vaccinated people. The downside is that many people are likely spreading the virus unintentionally.”

Amid ongoing criticism of the CDC’s response to COVID-19, monkeypox, and other public-health threats, the CDC announced on Wednesday that it will undergo an organizational “reset.” More concrete details are expected soon, but this will include staffing changes and taking steps to speed up releasing data to the public.

Meanwhile, in Brazil, federal police are calling on the country’s Supreme Court to charge President Jair Bolsonaro with the crime of incitement—encouraging others to commit a crime—based on his spreading of misinformation about the coronavirus. This includes falsely claiming vaccinated people were developing AIDS. To date, more than 680,000 people in Brazil have died due to COVID-19.


Thanks for reading. We hope you find the Coronavirus Brief newsletter to be a helpful tool to navigate this very complex situation, and welcome feedback at coronavirus.brief@time.com. If you have specific questions you'd like us to answer, please send them to covidquestions@time.com.

If you were forwarded this and want to sign up to receive it twice a week on Mondays and Thursdays, click here.

Today's newsletter was written by Kyla Mandel and edited by Mandy Oaklander.

 
TIME may receive compensation for some links to products and services in this email. Offers may be subject to change without notice.
 
Connect with TIME via Facebook | Twitter | Newsletters
 
    UNSUBSCRIBE    PRIVACY POLICY   YOUR CALIFORNIA PRIVACY RIGHTS
 
TIME Customer Service, P.O. Box 37508, Boone, IA 50037-0508
 
Questions? Contact coronavirus.brief@time.com
 
Copyright © 2022 TIME USA, LLC. All rights reserved.

沒有留言:

張貼留言